Provided by Tiger Fintech (Singapore) Pte. Ltd.

TFF Pharmaceuticals

0.0650
+0.0000
Volume:- -
Turnover:- -
Market Cap:288.80K
PE:-0.01
High:0.0650
Open:0.0650
Low:0.0650
Close:0.0650
Loading ...
Mar 06, 2025

Voluntary Delisting

Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
Mar 06, 2025

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Mar 06, 2025

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Mar 06, 2025

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Mar 06, 2025

Major Issues Report

Form 8-K - Current report
Feb 03, 2025

Major Issues Report

Form 8-K - Current report
Dec 10, 2024

Major Issues Report

Form 8-K - Current report
Nov 20, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 20, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 15, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Aug 15, 2024

Major Issues Report

Form 8-K - Current report
Aug 15, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2024

Major Issues Report

Form 8-K - Current report
Jun 29, 2024

Major Issues Report

Form 8-K - Current report
Jun 14, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 07, 2024

Major Issues Report

Form 8-K - Current report
May 17, 2024

Major Issues Report

Form 8-K - Current report
May 15, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]